Ondine Biomedical (OBI) Competitors

PureTech Health (LON:PRTC) and Ondine Biomedical (LON:OBI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

Which has stronger earnings & valuation, PRTC or OBI?

Ondine Biomedical has lower revenue, but higher earnings than PureTech Health. PureTech Health is trading at a lower price-to-earnings ratio than Ondine Biomedical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PureTech Health	£521.32K	745.59	-£91.86M	-£24.38	-5.31
Ondine Biomedical	C$48.60K	2,080.24	-C$424.66K	-C$3.32	-4.24

Does the media refer more to PRTC or OBI?

In the previous week, PureTech Health had 2 more articles in the media than Ondine Biomedical. MarketBeat recorded 3 mentions for PureTech Health and 1 mentions for Ondine Biomedical. PureTech Health's average media sentiment score of 1.47 beat Ondine Biomedical's score of 0.44 indicating that PureTech Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PureTech Health	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Ondine Biomedical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer PRTC or OBI?

PureTech Health currently has a consensus target price of GBX 455, suggesting a potential upside of 251.62%. Given PureTech Health's stronger consensus rating and higher possible upside, research analysts clearly believe PureTech Health is more favorable than Ondine Biomedical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PureTech Health	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Ondine Biomedical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do institutionals & insiders hold more shares of PRTC or OBI?

79.9% of PureTech Health shares are owned by institutional investors. Comparatively, 20.6% of Ondine Biomedical shares are owned by institutional investors. 15.9% of PureTech Health shares are owned by insiders. Comparatively, 36.7% of Ondine Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Is PRTC or OBI more profitable?

Ondine Biomedical has a net margin of -873.84% compared to PureTech Health's net margin of -17,620.94%. PureTech Health's return on equity of -21.15% beat Ondine Biomedical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PureTech Health	-17,620.94%	-21.15%	-13.39%
Ondine Biomedical	-873.84%	-684.01%	-159.71%

Which has more volatility and risk, PRTC or OBI?

PureTech Health has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Ondine Biomedical has a beta of 0.1, indicating that its stock price is 90% less volatile than the S&P 500.

Summary

PureTech Health beats Ondine Biomedical on 10 of the 16 factors compared between the two stocks.